In conclusion, gypenoside is speculated to inhibit the growth of gastric cancer cells by enhancing the antitumor immunity of T cells, possibly through modulating the expression of PD-L1 on the surface of gastric cancer cells. The gene discussed is CD274; the disease is gastric cancer.